← Back to headlines
Lundbeck's Migraine Drug Sales Drive Growth
Danish pharmaceutical company Lundbeck reported an 11 percent increase in revenue to 13.6 billion kroner in the first half of the year, primarily driven by sales of its migraine medication.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
